Jülide Gülizar YILDIRIM
(İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Halk Sağlığı Hemşireliği Anabilim Dalı, İzmir,Türkiye)
Ayla Bayık TEMEL
(Ege Üniversitesi Hemşirelik Fakültesi Halk Sağlığı Hemşireliği Anabilim Dalı, İzmir, Türkiye)
Yıl: 2020Cilt: 28Sayı: 1ISSN: 2147-4923 / 2687-6442Sayfa Aralığı: 13 - 22İngilizce

69 0
The Effect of Nurse Home-Support Program on Self-Management of Patients Receiving Oral Anticoagulation (Warfarin) Therapy
Aim: Warfarin, which is widely used for preventing thromboembolic events, can cause major and minor side effects. The aim of this trial is to evaluate the effect of nurse home-support program on self-management of patients receiving warfarin therapy.Method: A randomized, controlled trial was conducted using 36 selected and eligible patients who had 12-month home-visit follow-ups. The bleeding risk score, potential and preventable warfarin-related complications, patients’ self-management behaviors, and anticoagulation satisfaction were examined. Data analyses were performed using parametric and nonparametric tests, split-plot analysis of variance, multiple regression analysis, and Bland and Altman plots test.Results: The bleeding risk score was an effective variable for assessing patient satisfaction (p<0.05). The self-management group demonstrated decreased bleeding risk at the end of the trial. The Duke Anticoagulation Satisfaction Scale mean score represents a statistically significant improvement in the self-management group (p<0.05). Patients’ self-management behaviors improved significantly in the self-management group compared to the control group (p<0.05). The number of international normalized ratio values within the target range was significantly higher in the self-management group (174/432) than in the control group (82/432). The self-management group showed significant reductions in both thromboembolic events.Conclusion: This trial demonstrated evidence that use of nursing home care is effective in developing self-management behaviors, improving patient satisfaction, and preventing complications in patients receiving warfarin therapy. This model could be easily adopted and implemented by home care services and health organizations.
DergiAraştırma MakalesiErişime Açık
  • Ageno, W., Gallus, A. S. Wittkowsky, A., Crowther, M., Hylek, E. M., & Palareti, G. (2012). Oral anticoagulant therapy: Anti-thrombotic therapy and prevention of thrombosis, 9th edi-tion: American College of chest physicians evidence-based clinical practice guidelines. Chest,141(2 Suppl), e44S-e88S. [CrossRef]
  • Ansell, J., Jacobson, A., Levy, J., Völler, H., & Hasenkam, J. M. (2005). International self-monitoring association for oral anticoagulation. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagu-lation. International consensus guidelines prepared by inter-national self-monitoring association form oral anticoagula-tion. Int J Cardiol,99(1), 37-45. [CrossRef]
  • Beyth, R., Quinn, L., & Landefeld, C. (2000). A multicompo-nent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med, 133(9), 687-695. [CrossRef]
  • Bland, J. M., & Altman, D. G. (2003). Applying the right sta-tistics: Analyses of measurement studies. Lancet, 22(1), 85-93. [CrossRef]
  • Clarkesmith, D. E., Pattison, H. M., Khaing, P. H., & Lane, D. A. (2017). Educational and behavioural interventions for anti-coagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev,5(4), CD008600. [CrossRef]
  • CONSORT group. (2010). CONSORT 2010 statement: reporting of crossover randomised trials. Retrieved from https://www.equator-network.org/reporting-guidelines/consort-2010-statement-extension-to-randomised-cross-over-trials/
  • Fitzmaurice, D. A., Murray, E. T., McCahon, D., Holder, R., Raftery, J. P., Hussain, S., et al. (2005). Self-management of oral anticoagulation: Randomised trial. BMJ, 331(7524), 1057. [CrossRef]
  • Fitzmaurice, D. A., Murray, E.T., Gee, K. M., Allan, T. F., & Hobbs, F. D. (2002). A randomized controlled trial of patient self-management of oral anticoagulation treatment com-pared with primary care management. J Clin Pathol,55(11), 845-849. [CrossRef]
  • Garcia-Alamino, J. M., Ward, A. M., Alonso-Coello, P., Pere-ra, R., Bankhead, C., Fitzmaurice, D., & Heneghan, C. J. (2010). Self-monitoring and self-management of oral anticoagulation (Review). Cochrane Database Syst Rev,14(4), CD003839. [CrossRef]
  • Heiss, G. L. (2013). Health promotion and risk reduction in the community. In: Maurer FA, Smith CM. (Eds.), Community / public health nursing practice: Health for families and popula-tions (pp. 468-499, 5th ed.). USA: Elsevier.
  • Hua, T. D., Vormfelde, S. V., Abu Abed, M., Schneider-Rudt, H., Sobotta, P., Friede, T., et al. (2011). Practice nursed-based, individual and video assisted patient education in oral antico-agulation-Protocol of a cluster-randomized controlled trial. BMC Fam Pract,12(17), 2-5. [CrossRef]
  • Kılıç, S., Çelik, A., Çakmak, H. A., Afşin, A., Tekkeşin, A. İ., Açıksarı, G., et al. (2017). The time in therapeutic range and bleeding complications of warfarin in different geographic re-gions of Turkey: A subgroup analysis of WARFARIN-TR study. Balkan Med J, 34, 349-355. [CrossRef]
  • Kılıç, S., Çelik, A., Çekirdekçi, E., Alta, S., Elçik, D., Akboğa, M., et al. (2019). The prevalence and risks of inappropriate combination of aspirin and warfarin in clinical practice: Re-sults from WARFARIN-TR study. Balkan Med J,36, 17-22. [CrossRef]
  • Leech, L. N., Barrett, C. K., & Morgan, A. G. (Ed.). 2008. SPSS for intermediate statistics use and interpretation. New York, NY: Lawrence Erlbaum Associates.
  • McBane, R. D., Felty, C. L., Hartgers, M. L., Chaudhry, R., Beyer, L.K., & Santrach, P. J. (2005). Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs. Mayo Clin Proc,80(2), 181-186. [CrossRef]
  • Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J., & Lip, G. Y. (2010). A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. Chest, 138(5), 1093-1100. [CrossRef]
  • Research randomizer. (1997). Research randomizer pro-gram. Retrieved from https://www.randomizer.org/
  • Rollnick, S., Miller, W. R., & Butler, C. C. (2008). Motivational interviewing in health care. Helping patients change behavior. New York, NY: Guilford Press.
  • Ruiz-Nodar, J. M., Marín, F., Roldán, V., Valencia, J., Manza-no-Fernández, S., Caballero, L., et al. (2012). Should we rec-ommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv, 5(4), 459-466. [CrossRef]
  • Samsa, G., Matchar, D. B., Dolor, R. J., Wiklund, I., Hedner, E., Wygant, G., et al. (2004). A new instrument for measur-ing anticoagulation-related quality of life: Development and preliminary validation. Health Qual Life Outcomes, 2(22), 1-11. [CrossRef]
  • Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Bar-on-Esquivias, G., Baumgartner, H., et al. (2013). Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). G Ital Cardiol (Rome),14(3), 167-214.
  • Völler, H., Dovifat, C., Glatz, J., Körtke, H., Taborski, U., & Wegscheider, K. (2004). Self-management of oral anticoagu-lation with the IN Ratio system: Impact of a structured teach-ing program on patient’s knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil, 11(5), 442-447. [CrossRef]
  • Whitlock, E. P., Orleans, C. T., Pender, N., & Allan, J. (2002). Evaluating primary care behavioral counselling interventions: An evidence based approach. Amer J Prev Med,22(4), 267-284. [CrossRef]
  • Yıldırım, J. G. (2013). Yaşamınızı nasıl dengede tut-abilirsiniz? Pıhtı-önler ilaç (Varfarin/ Coumadin) kullanan hastalar için bakım rehberi (1. bs). Istanbul: Kazmaz Mat-baacılık.
  • Yıldırım, J. G., & Bayık-Temel, A. (2014). The validity and re-liability of Turkish version of the Duke Anticoagulation Satis-faction Scale. Turk J Thorac Cardiovasc Surg, 22(4), 761-772. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.